By Greg Freiherr, Editor, gfreiherr@cmp.comWe all have favorite jokes. One of mine is about the chairman of the board who's looking for a new corporate president. He invites
By Greg Freiherr, Editor, gfreiherr@cmp.com
We all have favorite jokes. One of mine is about the chairman of the board who's looking for a new corporate president. He invites the director of engineering, vice president of marketing, and CFO to apply. In the interviews, he asks each for the sum of one plus one. The selection process is delayed because the engineer insists on running a sophisticated algorithm and the marketing VP must convene a focus group. Both come up with "two." The CFO, however, takes very little time to render his answer. Having heard the question, he rises from his seat, closes the blinds on the windows, locks the door to the office, and says, leaning close to the chairman, "I can make one plus one anything you want it to be."
I told this joke a couple of years ago at the RSNA meeting to a former CFO who became the president of a small company. The two of us laughed and laughed. I told it again a couple of days ago. As before, I got a chuckle with the engineer's use of an algorithm and a chortle with the marketing director's use of a focus group. But the punch line went over like a lead balloon.
"Greg," my audience of one said. "I don't think you should tell that one any more."
Strange how things can change. You can't pick up a newspaper or watch Dan Rather without hearing about corporate fraud. When Congress asks Martha Stewart to testify about her alleged insider trading of ImClone, you know it's gone too far.
I never really paid much attention to Martha Stewart, so I can't say much about Martha, the person. But whenever I saw her on TV or in an ad, especially when she was holding a pie, she just looked so . . . wholesome.
Her troubles are annoying for me, because I once owned ImClone. I got out before the nosedive, but I wasn't so lucky with Enron. I'm considering redecorating the walls of my bathroom with Enron stock certificates. I'm told they have other uses in that room, as well.
But seriously, I've learned an important lesson from the last few months--the importance of keeping your sense of humor. It's also been comforting to note that I cover one of the few industries that has been free from scandal.
Personally, I think it's because of the caliber of people. Now if I could just get some of these guys to lighten up a bit.
*The rest of you folks hang in there.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.